Ionis Pharmaceuticals IONS Operating Segments — Royalty Revenue
Discontinued — last reported Q4 '17
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RoyaltyRevenue.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 28, 2018, on SEC EDGAR. View the filing →
Questions, answered.
- What does operating segments — royalty revenue mean?
- Revenue earned by a segment from licensing intellectual property to others.
- How do you interpret operating segments — royalty revenue?
- Increasing royalty revenue signals successful commercialization of licensed assets by partners.
- How does operating segments — royalty revenue compare across companies?
- Common in biotech companies that utilize a partnership-heavy business model.